Navigation Links
Simcere Pharmaceutical Group Reports Unaudited First Quarter 2009 Results
Date:5/18/2009

8,937 Interest income 10,407 2,569 376 Interest expense (482) (2,503) (366) Foreign currency exchange gains/(losses) 26,554 (84) (12) Earnings before income taxes 135,683 61,054 8,935 Income tax expense (16,782) (7,592) (1,111) Net income 118,901 53,462 7,824 Less: Net income attributable to the noncontrolling interest (6,784) (5,288) (774) Net income attributable to Simcere 112,117 48,174 7,050 Earnings per share attributable to Simcere: Basic 0.90 0.40 0.06 Diluted 0.88 0.40 0.06 Earnings per ADS attributable to Simcere: Basic 1.79 0.80 0.12 Diluted 1.76 0.80 0.12 Weighted average number of common shares: Basic 125,007,793 120,624,814 120,624,814 Diluted 127,645,885 120,624,814 120,624,814 Simcere Pharmaceutical Group UNAUDITED CONSOLIDATED CONDENSED Balance SheetS (Amounts expressed IN THOUSANDS) December 31, March 31, March 31, 2008 2009 2009 RMB RMB USD Assets Current assets Cash, cash equivalents and restricted cash 813,766 825,501 120,813 Accounts and bills receivables, net
'/>"/>
SOURCE Simcere Pharmaceutical Group
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Simcere Pharmaceutical Group to Announce 2009 First Quarter Earnings on Monday, May 18, 2009
2. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2008 Results
3. Simcere Pharmaceutical Group to Announce 2008 Fourth Quarter and Full Year Earnings On Thursday, March 12, 2009
4. Simcere Pharmaceutical Group Announces Preliminary Full Year Revenue and Earnings
5. Simcere Pharmaceutical Group to Participate in Morgan Stanley Seventh Annual Asia Pacific Summit 2008
6. Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2008 Results and Announces Share Repurchase
7. Simcere Pharmaceutical Group to Announce Third Quarter 2008 Earnings on Thursday, November 6, 2008
8. Simcere Pharmaceutical Group Announces Two Senior Promotions and Appointment of New Vice President of Human Resources
9. Simcere Pharmaceutical Group to Announce Second Quarter 2008 Earnings on Tuesday, August 5, 2008
10. Simcere Pharmaceutical Group to Participate in Upcoming Investor Conferences in New York
11. Simcere Pharmaceutical Group to Participate in Credit Suisse 3rd Annual Healthcare Trip

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...re/ -- Veridiam (www.veridiam.com) won the prestig...y at the 2009 Workplace Excellence Awards. The awa...an Resources Management and recognize innovative a...ridiam was one of nine winners, selected from more... the recent awards ceremony. San Diego-based Verid...
(Date:11/20/2009)...RNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NV...itten public offering of 6,800,000 shares of its c...share. The approximately $21 million of net proce...d commissions, will be used for preclinical studie...nternal research and development programs, working...
(Date:11/20/2009)...wire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (...th Circuit Court of Appeals reversed a U.S. Distri...d to pursue all of its claims against The Lash Gro...r trial. CTI filed a complaint against The Lash G...ltant for CTI,s product TRISENOX, in 2007 seeking ...
(Date:11/20/2009)...O recently announced that Dr. Dominique Hebrault w...cess Analytical Technology (PAT) in Green Chemistr.... , (PRWEB) November 20, ... Technology (PAT) in Green Chemistry and Green Eng...l Technology (PAT) case studies will be presented ...
Breaking Biology Technology:Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Novavax Prices Public Offering of Common Stock 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2
...er, Inc. (NYSE: BEC ), a leading developer, manu...utomate and innovate complex biomedical testing, t... shares of its common stock, the proceeds of which...ly announced acquisition of the diagnostic systems...iness, or the acquisition. Morgan Stanley & C...
..., May 19 InfraReDx, Inc. announced today the firs...t uses both light and sound to image coronary plaq... Dr. Martin van der Ent performed the procedures o...iography at the Thoraxcenter. , , The combinati... NIRS imaging in a single study of the artery. IV...
...irstCall/ -- China Sky One Medical,Inc. ("China Sk..., a leading,fully integrated pharmaceutical compan... Republic of China ("PRC"), today announced that i...t the Company in complying with the,financial repo...ct Section 404,("SOX 404") by December 31, 2009. ,...
Other Biology Technology:Beckman Coulter, Inc. Announces Pricing of Common Stock Offering 2Beckman Coulter, Inc. Announces Pricing of Common Stock Offering 3First Use in Coronary Patients of a Combined Near-Infrared Spectroscopy and Ultrasound Imaging Catheter 2First Use in Coronary Patients of a Combined Near-Infrared Spectroscopy and Ultrasound Imaging Catheter 3China Sky One Medical, Inc. Appoints Pricewaterhouse Coopers to Help Develop a SOX 404 Compliance Program 2China Sky One Medical, Inc. Appoints Pricewaterhouse Coopers to Help Develop a SOX 404 Compliance Program 3
(Date:11/23/2009)...Current research suggests that a common oral bacte...ed report by Nichols et al, "Unique Lipids from a ...R2 Ligands Capable of Enhancing Autoimmunity," app...ournal of Pathology . , Multiple sclerosis (MS),...in and spinal cord, affects nearly 1 in 700 people...
(Date:11/23/2009)...ember 16, 2009 -- A USDOE and USDA study concluded...land, and cropland pasture could be converted from...es, such as switchgrass, from which biomass could ...mically viable production of a perennial grass mon...ass are removed annually is expected to require ni...
(Date:11/23/2009)...Southern California biomedical engineer and cardio...ool to help clinicians distinguish cardiac emergen...lems manageable with drugs and lifestyle change. ,...nto the arteries feeding the heart, offer an insid...blood vessels, often revealing deposits of a dange...
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Switchgrass produces biomass efficiently 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2Scientists take step toward simple and portable tuberculosis tests for developing world 10305 1Scientists take step toward simple and portable tuberculosis tests for developing world 10305 2Scientists take step toward simple and portable tuberculosis tests for developing world 10305 3New Technology Shows Human Genome in 3 D 59166 1New Technology Shows Human Genome in 3 D 59166 2San Diego Hospice and The Institute for Palliative Medicine Program Wins National American Psychiatric Association Gold Achievement Award 59164 1San Diego Hospice and The Institute for Palliative Medicine Program Wins National American Psychiatric Association Gold Achievement Award 59164 2
...he creation of reading matter, a "nano-printing" t...oduction of nano-devices currently built one at a ...ovation is the DNA microarray, a nano-device used ...as Alzheimer,s, viral illnesses such as AIDS, and ...duce these complex devices would make DNA analysis...
...ndard for treating newborns suffering from opiate ...iates themselves are superior to sedatives for tre...hadone while pregnant. , Opiates appear to better ... potentially reduce the likelihood of seizures," a...id Osborn, a neonatologist at the Royal Prince Alf...
... and rats in combination with an animal model of o...as given researchers new insight in the developmen...n the September issue of Kidney International. , "... it takes a fair amount of time to install," state... Bugnard inFrance. "This animal model has the adv...
Other Biology News:New technique may speed DNA analysis 2Opiates Better Than Sedatives For Treating Newborns In Withdrawal 2
Streptavidin, PE conjugated/tagged from Invitrogen
Supercoiled DNA Ladder from Invitrogen
GIBCO RPMI Medium 1640; powder from Invitrogen
Rabbit Anti-Human Parathyroid Hormone Receptor 2 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: